Glaucoma

Announcing the FFB’s Vision Care Pathways

September 27th, 2018 by FFB Canada

Along with the brain, the eye is one of the human body’s most intricate components, an elaborate collection of parts working in tandem to do one thing: gather external light and focus it on a small area of tissue at the back of the eye. Cells housed in the tissue absorb light particles and transmit…

Read More

Are You Living with Glaucoma?

July 23rd, 2018 by FFB Canada

Are you currently living with glaucoma? If so, we at the Foundation Fighting Blindness would like to learn about your experiences with the disease so that we can help build a better future for glaucoma patients. Please click on the link below to complete our survey on glaucoma. It should only take 10 minutes of…

Read More

RNA Therapies for Inherited Retinal Diseases (IRDs)

May 1st, 2018 by Dr. Mary Sunderland

I recently participated in a tremendously inspiring meeting, hosted by ProQR, which is a company that is creating new treatments for people living with rare diseases, including blinding eye diseases. ProQR specializes in developing RNA therapeutics, and I was there to learn about a new clinical trial that they are planning to treat the inherited…

Read More

Four Vision Research and Treatment Trends to Watch in 2018   

January 22nd, 2018 by FFB Canada

With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U. S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year for gene therapy. Looking back, 2017 was a year of firsts, including the first stem cell therapy clinical trial for macular degeneration…

Read More

2017 in Review: The Most-Read FFB Stories of 2017

December 22nd, 2017 by FFB Canada

At the FFB, we love writing about vision research. In 2017, we wrote more than 50 stories to share news about stem cell discoveries, CRISPR gene-editing, promising new drug therapies, and emerging treatments for blinding eye disease. Have you read them all? The best place to start is with our top 10 most-read stories of…

Read More

Top 10 Things We Learned at Vision Quest 2017

November 7th, 2017 by Dr. Mary Sunderland

Vision Quest is the FFB’s educational program series that brings trusted information about emerging sight-saving treatments to people living with vision loss. This year, Vision Quest brought together more than 860 people at 9 different events across Canada. The entire FFB staff participates in Vision Quest because it gives us the opportunity to learn directly…

Read More

Clinician-Scientist Emerging Leader Award: Dr. Brian Ballios

November 1st, 2017 by FFB Canada

Dr. Brian Ballios has restored vision in mice, but he is not stopping there. He is on a mission to develop stem cell therapies for people living with blindness and has a plan to get there. Dr. Ballios and other clinician-scientists are essential players in the translation of pre-clinical vision research into clinical trials and…

Read More

New Master Control Gene Provides Key Insights into Restoring Vision

October 31st, 2017 by Dr. Chad Andrews

With support from the FFB community, Dr. Michel Cayouette’s research is advancing the field of stem cell therapy in extraordinary ways; it is doing so by illuminating how stem cells are produced, how they turn into other cells, and the role they play in the overall biology of the human eye. Dr. Cayouette’s ultimate goal?…

Read More

FDA Panel Votes Unanimously to Approve New Gene Therapy

October 13th, 2017 by Dr. Mary Sunderland

History was made on World Sight Day, October 12, 2017, when an FDA advisory panel voted unanimously to approve a new gene therapy, Luxturna, designed to treat inherited blinding eye diseases caused by mutations in the RPE65 gene. We have been following this story closely over the past few years and celebrating every milestone along…

Read More

World’s First Experimental Therapy Involving Reprogrammed Donor Stem Cells Aims to Treat Macular Degeneration

April 4th, 2017 by FFB Canada

Stem cells are frequently in the news. At the FFB, we love reading about stem cell discoveries, but high-frequency reporting can make it challenging to identify truly significant breakthroughs, such as the one from last week: “Japanese man is the first to receive ‘reprogrammed’ stem cells from another person.” The story, published in a prestigious…

Read More